Use of the plasma CTX for assessing the bone activity of the mandible among osteopenic and osteoporotic patients

Brazilian Oral Research

Volumn 24, Issue 2, 2010, Pages 250-255

  Avolio, Glacio ^a   Brandão, Cynthia ^a   Marcucci, Marcelo ^a   Alonso, Gilberto ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Biological markers; Bone diseases, metabolic; Mandible

Indexed keywords

BIOLOGICAL MARKER; ICTP PEPTIDE; PEPTIDE FRAGMENT; PROCOLLAGEN;

ARTICLE; BLOOD; BONE DENSITY; BONE REMODELING; DENSITOMETRY; FEMALE; FEMUR; HUMAN; MANDIBLE; METABOLISM; MIDDLE AGED; PHOTON ABSORPTIOMETRY; PHYSIOLOGY; POSTMENOPAUSE OSTEOPOROSIS; SCINTISCANNING; STATISTICAL MODEL;

ABSORPTIOMETRY, PHOTON; BIOLOGICAL MARKERS; BONE DENSITY; BONE REMODELING; DENSITOMETRY; FEMALE; FEMUR; HUMANS; LINEAR MODELS; MANDIBLE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; PEPTIDE FRAGMENTS; PROCOLLAGEN;

EID: 77955546843     PISSN: 18068324     EISSN: 18073107     Source Type: Journal    
DOI: 10.1590/S1806-83242010000200020     Document Type: Article

References (22)

1. Lewiecki EM, Binkley N. Evidence-based medicine, clinical practice guidelines, and common sense in the management of osteoporosis. Endocr Pract. 2009 Sep-Oct;15(6):573-9.
2. Kanis JA, Melton LJ, Christianse C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res. 1994 Aug;11(8):1199-201.
3. Hughes DE, Wright KR, Uy HL, Sasaki A, Yoneda T, Roodmam GD, et al. Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res. 1995 Oct;10(10):1478-87.
4. Kribbs PJ, Chesnut CH III, Ott SM, Kilkoyne RF. Relationships between mandibular and skeletal bone in an population of normal women. J Prosthet Dent. 1990 Jan;63(1):86-9.
5. Von Wowern N, Klausen B, Kollerup G. Osteoporosis: a risk factor in periodontal disease. J Periodontol. 1994 Dec;65(12): 1134-8.
6. Marx R. Pamidronate (Aredia) and zoledronate (Zometa) inducci avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg. 2003 Sep;61(9):1115-7.
7. Bagan JV, Murillo J, Jimenez Y, Poveda R, Milian MA. Avascular jaw osteonecrosis in association with cancer chemotherapy: series of 10 cases. J Oral Pathol Med. 2005 Feb;34(2):120-3.
8. Garnero P, Borel O, Delmas PD. Evaluation of a Fully Automated Serum Assay for C-Terminal Cross-Linking Telopeptide of Type I Collagen in Osteoporosis. Clin Chem. 2001 Apr;47(4):694-702.
9. Vieira JG. Considerações sobre os marcadores bioquímicos do metabolismo ósseo e sua utilidade prática. Arq Bras Endocrinol Metabol. 1999 Dez;43(6):415-22.
10. Bikle DD. Biochemical markers in the assessment of bone disease. Am J Med. 1997 Nov;103(5):427-36.
11. Donohoe KJ, Henkin RE, Royal HD, Brown ML, Collier BD, Omara RE et al. Procedure guidelines for bone scintigraphy: 1.0 Society of Nuclear Medicine. J Nucl Med. 1996 Nov;37(11):1903-6.
12. Fogelman I, Collier BD, Brown ML. Bone scintigraphy; part bone scanning in metabolic bone disease. J Nucl Med 1993 Dec; 34(12):2247-52.
13. Livingston S, Berman W, Pauli LL. Anticonvulsivant Drugs and Vitamin D Metabolism. JAMA. 1973 Jun;224(12):1634-5.
14. Haller J, André MP, Resnick D, Miller C, Howard SA, Mitchell MJ. Detection of thorocolumbar vertebral body destruction with lateral spine radiography. Part I: Investigation in cadavers. Invest Radiol. 1990 May;25(5):517-22.
15. Rey C, Combes C, Drouet C, Glimcher MJ. Bone mineral: an update on chemical composition and structure. Osteoporos Int. 2009 Jun;20(6):1010-21.
16. Seibel MJ. Molecular Markers of bone turnover: biochemical, technical analytical aspects. Osteoporos Int. 2000; 11 Suppl 6:S18-29.
17. Heshmati HM, Riggs BL, Burrit MF, McAlister CA, Wollan PC, Khosla S. Effects of the circadian variation in serum cortisol on markers of bone turnover and calcium homeostasis in normal postmenopausal women. J Clin Endocrinol Metab. 1998 Mar;83(3):751-6.
18. Mulligan R, Sobel S. Osteoporosis: diagnostic testing, interpretation, and correlations with oral health-implications for dentistry. Dent Clin North Am. 2005 Apr;49(2):463-84.
19. Garnero P, Delmas PD. Biochemical markers of bone turnover - applications for Osteoporosis. Endocrinol Metab Clin North Am. 1998 Jun;27(2):303-23.
20. Garnero P, Sornay-Rendu E, Duboeuf F, Delmas F. Markers of Bone Turnover Predict Postmenopausal Forearm Bone Loss Over 4 Years: The OFELY Study. J Bone Miner Res. 1999 Sep;14(9):1614-21.
21. Marx RE, Cillo JE, Ulloa JJ. Oral Bisphosphonate-Induced Osteonecrosis: Risk Factors, Prediction of Risk Using Serum CTX Testing, Prevention, and Treatment. J Oral Maxillofac Surg. 2007 Dec;65(12):2397-410.
22. Blumsohn A, Eastell R. The performance and utility of biochemical markers of bone turnover: do we know enough to use them in clinical practice? Ann Clin Biochem. 1997 Sep;34(Pt5):449-59.